BioLamina AB and partners granted € 6,1M in funding to develop organ-on-chip system for animal-free modelling of human diseases

Organ-on-chip technologies hold promise in accurately and better than animal models, mimic human organs and organ systems in vitro and have great potential to be game-changing in life science research, drug discovery and drug development.